Amgen (Nasdaq: AMGN) has reported stronger-than-expected third-quarter results, driven by double-digit gains across several ...

California-based Azalea Therapeutics, a biotech promising to redefine precision genomic medicines in vivo, has announced its ...

Novo Nordisk presented new data from the OASIS 4 Phase III trial that explored a variety of patients and hypotheses, adding ...

Less than six months after ending a short-lived partnership, US telehealth firm Hims & Hers (Nasdaq: HIMS) and Danish ...

US biopharma firm Viridian Therapeutics today announced the successful submission of its biologics license application (BLA) to the US Food and Drug Administration (FDA) for veligrotug, the company’s ...

Sweden’s Moberg Pharma has entered into an exclusive licensing agreement with Karo Healthcare regarding the commercialization ...

Swiss generics and biosimilars major Sandoz has announced a strategic agreement with Germany’s Evotec to acquire all issued ...

Danish pharma major Novo Nordisk today announced financial results for the first nine months of 2025, showing that group net ...

China’s National Medical Products Administration (NMPA) in China has recently approved Sichuan Kelun Biotech’s Sutaray (trastuzumab botidotin) for the treatment of adult patients with unresectable or ...

Trade group Pharmaceutical Research and Manufacturers of America (PhRMA) recently submitted comments to inform the Office of ...

US pharma giant Pfizer (NYSE: PFE) reported financial results for the third quarter of 2025 on Tuesday. Revenues for the ...

The bidding war for US obesity focused biotech Metsera, which has attracted offers from Pfizer and Novo Nordisk , and ...